Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 41.40
Change Today +0.60 / 1.47%
Volume 25.0K
NXGN On Other Exchanges
Symbol
Exchange
Tel Aviv
As of 9:24 AM 08/30/15 All times are local (Market data is delayed by at least 15 minutes).

nextgen biomed ltd (NXGN) Snapshot

Open
$40.80
Previous Close
$40.80
Day High
$41.90
Day Low
$41.10
52 Week High
11/30/14 - $449.14
52 Week Low
08/24/15 - $39.00
Market Cap
4.9M
Average Volume 10 Days
88.8K
EPS TTM
$-0.75
Shares Outstanding
11.9M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for NEXTGEN BIOMED LTD (NXGN)

Related News

No related news articles were found.

nextgen biomed ltd (NXGN) Related Businessweek News

No Related Businessweek News Found

nextgen biomed ltd (NXGN) Details

Nextgen Biomed Ltd develops drugs for topical treatments for skin diseases. It develops DPS-101, a product that is in the Phase II/b used for the topical treatment of psoriasis without steroids. Nextgen Biomed Ltd has a collaboration agreement with the Boston VA Research Institute Inc. for the realization of Phase II and III of clinical experiments in human beings of DPS. The Company was incorporated in 1990 and is based in Tel Aviv, Israel.

Founded in 1990

nextgen biomed ltd (NXGN) Top Compensated Officers

Chief Financial Officer
Total Annual Compensation: 70.0K
Compensation as of Fiscal Year 2013.

nextgen biomed ltd (NXGN) Key Developments

Nextgen Biomed Ltd expected to report Q2 2015 results on August 30, 2015. This event was calculated by Capital IQ (Created on June 23, 2015).

Nextgen Biomed Ltd expected to report Q2 2015 results on August 30, 2015. This event was calculated by Capital IQ (Created on June 23, 2015).

Nextgen Biomed Ltd, Special/Extraordinary Shareholders Meeting, May 06, 2015

Nextgen Biomed Ltd, Special/Extraordinary Shareholders Meeting, May 06, 2015., at 09:00 Israel Standard Time.

Nextgen Biomed Ltd, Special/Extraordinary Shareholders Meeting, Dec 22, 2014

Nextgen Biomed Ltd, Special/Extraordinary Shareholders Meeting, Dec 22, 2014., at 09:00 Israel Standard Time.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NXGN:IT 41.40 +0.60

NXGN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for NXGN.
View Industry Companies
 

Industry Analysis

NXGN

Industry Average

Valuation NXGN Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NEXTGEN BIOMED LTD, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.